A variant epidemic methicillin resistant Staphylococcus aureus-15 cavernous sinus thrombosis and meningitis: A rare occurrence with unusual presentation

Kumari, H. B. Veena; Nagaraja, D.; Nagarathna, S.; Kulkarni, G. B.; Praveen, C. S.; Nadig, S.; Arakere, G.
July 2010
Indian Journal of Medical Microbiology;Jul2010, Vol. 28 Issue 3, p255
Academic Journal
Case Study
Septic cavernous sinus thrombosis (CST) is an uncommon clinical syndrome. Although Staphylococcus aureus (S aureus) is the most common bacterial pathogen causing CST, it is infrequent as a cause of meningitis. We report the first case of CST and meningitis from Bengaluru, Karnataka, caused by community acquired epidemic methicillin resistant Staphylococcus aureus-15 (EMRSA-15), in a previously healthy individual without known risk factors; the patient recovered following treatment with vancomycin. The isolate was genotyped as belonging to staphylococcal cassette chromosome mec type IV and sequence type 22 and carried the panton-valentine leucocidin gene. It is the first Indian EMRSA-15 disease isolate from a case of meningitis. EMRSA-15 has been a major problem in hospitals in UK and it is a cause for great concern in Indian hospitals too.


Related Articles

  • Methicillin-resistant Staphylococcus aureus enteritis in an immunologically uncompromised infant. Kimata, H.; Kawahara, M. // European Journal of Pediatrics;1999, Vol. 158 Issue 5, p431 

    Describes a case of methicillin-resistant staphylococcus aureus (MRSA) entiritis in a five-month-old girl, who had no immunodeficiency or prior surgery. How oral administration of vancomycin hydrochloride (VCM) improved enteritis and eradicated MRSA without any adverse effect; Description of MRSA.

  • Antioxidant and Blood Brain Barrier Status in Cerebrospinal Fluid of Bacterial Meningitis Rat Model after Vancoplus Treatment. Soni, A.; Dwivedi, V. K.; Chaudhary, M.; Shrivastava, S.M. // Journal of Medical Sciences;2009, Vol. 9 Issue 4, p194 

    The aim of this study was to compare the efficacy of ceftriaxone, vancomycin and its fixed dose combination of ceftriaxone plus vancomycin (Vancoplus) for the treatment of meningitis induced by methicillin-resistant Staphylococcus aureus (MRSA) in rat model. The MRSA strain ATCC 43300 was used...

  • New Perspectives on Fluoroquinolones.  // Review of Optometry;6/15/2007 Supplement, Vol. 144, p14A 

    The article offers perspective on fluoroquinolones. It focuses on the article titled "In Vitro of Fluoroquinolones, Vanocomycin and Gentamicin Against Methicilin-Resistant Staphylococcus aureus (MRSA) Ocular Isolates" which concludes that MRSA ocular isolates exhibited a relatively high rate of...

  • Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus. Vaudaux, P.; Ferry, T.; Uçkay, I.; François, P.; Schrenzel, J.; Harbarth, S.; Renzoni, A. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2012, Vol. 31 Issue 12, p3367 

    We evaluated, by an improved susceptibility testing method, the prevalence and significance of low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus (MRSA) isolates, which belonged to a previously described, retrospective cohort of patients treated for orthopedic...

  • Superbugs are beating at the gates. Kmietowicz, Zosia // New Scientist;07/17/99, Vol. 163 Issue 2195, p22 

    Reports on strains of Staphylococcus aureus which are resistant to most conventional antibiotic drug treatments. Use of the unlicensed drug Synercid to kill the methicillin- resistant strain of S. aureus, which is also resistant to most other antibiotics; Mutations in the bacteria which render...

  • Vancomycin.  // Reactions Weekly;5/19/2012, Issue 1402, p43 

    The article describes the case of a 25-year-old man with a catheter-related methicillin-resistant staphyloccus infection who developed respiratory distress revealing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome while receiving treatment with vancomycin.

  • Reduction in vancomycin susceptibility may occur in MSSA.  // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p38 

    The article discusses a study that examined whether the evolution of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus is similar to that seen in methicillin-resistant Staphylococcus aureus.

  • Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-Resistant Staphylococcus aureua Endocarditis. Levine, Donald P.; Fromm, Barbara S.; Reddy, B. Ramesh // Annals of Internal Medicine;11/1/91, Vol. 115 Issue 9, p674 

    Determines the median response time of patients with methicillin-resistant Staphylococcus aureus endocarditis to vancomycin and rifampin antibiotics. Characteristics of the patients; Complications; Duration of bacteremia among the patients.

  • VANCOMYCIN DOSING FOR MRSA INFECTIONS. JOSEPH, WARREN S. // Clinical Advisor;Feb2012, Vol. 15 Issue 2, p61 

    A letter to the editor is presented in response to the article "Updated information on MRSA infections" in the December 2011 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics